Professional development Vacancies

Forum program

17.07.2023 Updated 21.07.2023 2302 views

PHARMACEUTICAL FORUM

“CLINICAL TRIALS IN UKRAINE. EUROPEAN INTEGRATION”

Held on JUNE 29, 2023

“MERCURE CONGRESS CENTRE”, Kyiv, Vadyma Hetmana St., 6

Program materials

8:30 – 9:30

REGISTRATION OF FORUM PARTICIPANTS
WELCOME COFFEE
Forum Moderator: Serhii Orlyk, pharmaceutical market expert

GRAND OPENING OF THE FORUM

welcome address

9:30 – 9:40

Serhii Dubrov, First Deputy Minister of Health of Ukraine, Doctor of Medical Sciences, Professor

9:40 – 9:50

Mykhailo Babenko, Director of the State Expert Center of the Ministry of Health of Ukraine, Candidate of Pharmaceutical Sciences, Associate Professor

PLENARY SESSION


Clinical trials.
GCP principles – the regulatory foundation for conducting clinical
trials in Ukraine during the war.
European integration

9:50 – 10:00
The Realities of Clinical Trials in UkraineMykhailo Lobas, Deputy Director for Clinical Affairs of the State Expert Center of the Ministry of Health of Ukraine, Candidate of Medical Sciences, MBAPDF · 1.3 MB · 22.10.2026
10:00 – 10:15

Compassionate use of medicinal products in Ukraine. Expanded access programs

Taras Liaskovskyi, Head of the Pharmaceutical Directorate of the Ministry of Health of Ukraine

10:15 – 10:30
Clinical Trials in Ukraine Today and in the FutureIryna Mahdik, Executive Director of the Clinical Trials Subcommittee of the European Business Association, Candidate of Medical Sciences, MBA, Kyiv, UkrainePDF · 4.6 MB · 22.10.2026
10:30 – 10:45
What needs to be done today for the future of the clinical research sector in UkraineIvan Vyshnivetskyi, head of the public organization “Ukrainian Association of Clinical Research”, associate professor of the Department of Healthcare Management at Bogomolets National Medical University, Candidate of Medical Sciences, associate professorPDF · 468 KB · 22.10.2026
10:45 – 11:00

What the Clinical Trial Sponsor is doing today in Ukraine

Serhii Mykhailov, Director of Clinical Trials in Ukraine, Georgia and the CIS, MSD, Kyiv, Ukraine

11:00 – 11:20

European platform for clinical trials
A European platform for clinical trials

Language – English
Working language – English
Online /online

File 1 of 16Björn Ericsson, Director General of the Swedish Medical Products Agency, Sweden
Björn Ericsson, Director General of Swedish Medical Products Agency, Sweden
Gunilla Andrew-Nielsen, Head of the Department of Clinical Trials and Special Permissions of the Swedish Medical Products Agency, Sweden
Gunilla Andrew-Nielsen, Head of Department of Clinical Trials and Special Permissions of Swedish Medical Products Agency, Sweden
PDF · 615 KB · 22.10.2026
11:20 – 11:35
Experience of Conducting Clinical Trials During the WarKateryna Orlovska, Head of the Clinical Trial Quality Standards Assurance Group for Ukraine, Georgia, and the CIS, MSD, Kyiv, UkrainePDF · 2.6 MB · 22.10.2026
11:35 – 11:50
The informed consent procedure is a key element of protecting the rights of trial subjectsOlha Smoliar, Head of the Division of Specialized Expert Evaluation of Preclinical and Clinical Trial Materials of the Department of Expert Evaluation of Preclinical and Clinical Trial Materials of the State Expert Center of the Ministry of Health of UkrainePDF · 1.4 MB · 22.10.2026
11:50 – 12:05

Organization of the work of the ethics committee at the Municipal Non-Profit Enterprise “Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of the Cherkasy Regional Council”

Oksana Sokurets, Chair of the Ethics Committee at the Municipal Non-Profit Enterprise “Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of the Cherkasy Regional Council”, Cherkasy, Ukraine

12:05 – 12:20

Considerations on the context of clinical research in Ukraine:
conclusions of the ALLEA symposium on the crisis and the importance of research,
standardization of new technologies by the EU-US Trade and Technology Council, and data management in ICH E6(R3)

Considerations for Ukraine”s Clinical Research Context:
Learnings from ALLEA’s Symposium on Crisis and the Importance of Research, the EU-US Trade & Technology Council’s Standardization
for Emerging Technologies, and Data Governance in ICH E6(R3)

Language – English
Working language – English
Online /online

File 2 of 16Francis P. Crawley, Coordinator of the Ukraine Clinical Research Support Initiative (UCRSI), Executive Director of the Good Clinical Practice Alliance – Europe (GCPA) and the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER), EOSC-Future / RDA Ambassador for Ethics and Law, Chair of the CODATA International Data Policy Committee (IDPC), Member of the Ethics Working Group of the International Federation of Associations of Pharmaceutical Physicians (IFAPP), Leuven, Belgium
Francis P. Crawley, Coordinator, Ukraine Clinical Research Support Initiative (UCRSI), Executive Director, Good Clinical Practice Alliance – Europe (GCPA)
& Strategic Initiative for Developing Capacity in Ethical Review (SIDCER), EOSC-Future / RDA, Ambassador for Ethics & Law, Chair, CODATA International Data Policy Committee (IDPC), Member, Ethics Working Group, International Federation of Pharmaceutical Physicians” Associations (IFAPP), Leuven, Belgium
PDF · 337 KB · 22.10.2026
12:20 – 13:00

lunch

13:00 – 13:30

Panel discussion.

Organization of the trial site at a health care facility and specifics of its operation during martial law. Compliance with GCP requirements. Results of clinical audits.Serhii Rasputniak, Head of the Laboratory and Clinical Practices (GLP, GCP) Audit Division of the State Expert Center of the Ministry of Health of Ukraine

Lesia Yankova, Head of the Section of Clinical Audit of Clinical Trials, Division for Audit of Laboratory and Clinical Practices (GLP, GCP), State Expert Center of the Ministry of Health of UkrainePDF · 2.3 MB · 22.10.2026

13:30 – 13:45

Clinical Research in Extreme Conditions. Innovations Tested by WarIhor Bondarenko, Head of the Department of Oncology and Medical Radiology at Dnipro State Medical University, Doctor of Medical Sciences, Professor, Dnipro, UkrainePDF · 4 MB · 22.10.2026
13:45 – 14:00
Preclinical studies of medicinal products as a basis for clinical trials. Implementation of the guidelines of the European Medicines Agency (EMA) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)Mykhailo Kozlov, Head of the Preclinical Studies Audit Sector of the Laboratory and Clinical Practice Audit Directorate (GLP, GCP) of the State Expert Center of the Ministry of Health of Ukraine, Candidate of Medical SciencesPDF · 1.5 MB · 22.10.2026
14:00 – 14:15

Bioequivalence: components of success

Ihor Zupanets, Doctor of Medical Sciences, Professor, Honored Worker of Science and Technology of Ukraine, co-authored with Candidate of Medical Sciences, Associate Professor of the Department of Clinical Pharmacology and Clinical Pharmacy of the National University of Pharmacy Bezuhla N.

14:15 – 14:30
Bioequivalence studies in Ukraine. The situation over the last five years and expected prospects. Expert analysisNadiia Zhukova, Head of the Division for Expert Evaluation of Bioequivalence and Bioavailability Materials of the State Expert Center of the Ministry of Health of Ukraine, Candidate of Pharmaceutical SciencesPDF · 1.5 MB · 22.10.2026
14:30 – 14:45

Transfer of clinical trial participants from Ukraine to Poland due to the war

Transferring CT participants from Ukraine to Poland due to war

Language – English
Working language – English
Online /online

Eva Oldak,
adviser to the President’s Office of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Poland

Mikhal Hryz, Director of the Department of Inspection of Medicinal
Products and Medical Devices of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Poland

Ewa Ołdak, advisor in the Office of the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Poland

Michał Gryz , Director of Department of Inspection of Medicinal Products and
Medical Devices of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Poland

14:45 – 15:00

Clinical trials to the accompaniment of sirens. The experience of the National Cancer Institute

The War in Ukraine as a New Phase of Clinical TrialsYurii Ostapenko, Head of the Department of Minimally Invasive and Endoscopic Surgery and Interventional Radiology, SNE “National Cancer Institute”PDF · 2.7 MB · 22.10.2026
15:00 – 15:15

How the war in Ukraine changed our approach to clinical trials, using our experience and lessons learned

How the war in Ukraine has changed our approach to clinical trials based on our experiences and lessons learned

Language – English
Working language – English
Online /online

File 3 of 16Aneta Sitarska Haber, MD, Vice President of the GCP Association in Poland, Associate Director of Regional Operational Delivery in Poland, Clinical Research Group, PPD, part of Thermo Fisher Scientific
Aneta Sitarska Haber, MD Vice President GCP Association in Poland, Associate Director, Regional Operational Delivery-Poland, PPD part of Thermo Fisher Scientific
PDF · 1.8 MB · 22.10.2026
DISCUSSION OF THE TOPIC WITH THE AUDIENCE

Forum Moderator: Serhii Orlyk, pharmaceutical market expert

15:15 – 15:35
coffee break

JOINT SECTION/
JOINT SECTION

State Expert Center of MoH of Ukraine
&
Ukrainian Association for Clinical Research/
of the State Expert Center of the Ministry of Health of Ukraine and
the Ukrainian Association of Clinical Research


Ukrainian capabilities and opportunities
for international clinical research/
Ukraine's opportunities in the field of international clinical research
15:35 – 15:45

Language – English
Working language – English


Why Ukraine is important for global clinical development

Why Ukraine matters for the clinical research sector

File 4 of 16Ivan Vyshnyvetskyi, Head of the Ukrainian Association of Clinical Research, Managing Director of FutureMeds in Ukraine, Kyiv, UkrainePDF · 954 KB · 22.10.2026
15:45 – 16:00

Clinical Trials Sector in Ukraine during the War. Expert analysis

Clinical trials in Ukraine under martial law. Expert analysis

File 5 of 16Taisa Herasymchuk, Director of the Department of Expert Evaluation of Preclinical and Clinical Trial Materials of the State Expert Center of the Ministry of Health of Ukraine, Candidate of Pharmaceutical SciencesPDF · 6.5 MB · 22.10.2026
16:00 – 16:15

Success story: COVID-19 study in Ukraine during the war

Success story: COVID-19 research in Ukraine during wartime

Online/online

Sebastien Labbe,
Director, Preclinical and Clinical Development, Immune Biosolutions Inc, Canada

Bruno Maranda, M.D Chief Medical Officer, Immune Biosolutions Inc, Canada

Sebastien Labbe,
Director of Preclinical and Clinical Development, Immune Biosolutions Inc, Canada

Bruno Maranda,
Chief Medical Officer, Immune Biosolutions Inc, Canada

16:15 – 16:30

Demystifying clinical trial logistics in Ukraine during the war

Logistics of clinical trials under martial law: debunking myths

Olga Vizgalova,
Managing Director Oximio Ukraine

Olha Vizghalova,
Managing Director of Oximio Ukraine

16.30 – 16.45

Success story: Ulcerative Colitis study in Ukraine during the war

Online/on-line

Success story: a study of ulcerative colitis in Ukraine in wartimeJenny Sundqvist, CEO, InDex Pharmaceuticals, Sweden
Eva Arlander, Chief Development Officer, InDex Pharmaceuticals, Sweden
Jenny Sundqvist, CEO, InDex Pharmaceuticals, Sweden
Eva Arlander, Chief Development Officer, InDex Pharmaceuticals, Sweden
PDF · 1.1 MB · 22.10.2026
16.45 – 17.05

What it means to stay operational during the war: clinical sites experience

How to keep a site operating during war: the experience of research centers

Evgeny Levenko,
Country Manager ARENSIA Exploratory Medicine, Ukraine

Yevhen Levenko,
Regional Manager of ARENSIA Exploratory Medicine in Ukraine, Candidate of Medical Sciences

17.05 – 17.20

Experience conducting clinical trials in Ukraine during the COVID-19 pandemic and war

Experience of conducting clinical studies in Ukraine during the COVID-19 pandemic and the war

Jens D. Lundgren,
MD, DMSc, Director of Centre of Excellence for Health, Immunity and Infections, Copenhagen, Denmark

Jens D. Lundgren,
Prof., Director of the Center of Excellence for Health, Immunity and Infections, Copenhagen, Denmark

17.20 – 17.55

Panel discussion «Convincing sponsors to (re)start studies in Ukraine»
Panel discussion “How to convince sponsors to conduct studies in Ukraine”

Panelists:

Radoslaw Janiak, CEO of FutureMeds Ltd, UK (online)
Serhiy Mykhaylov, Clinical Research Director Ukraine, Georgia & CIS, MSD

Werner Gladdines, VP Program Management/Clinical Development Operations, Immunic Therapeutics, Germany (online)

Panel discussion participants:

Radoslav Yaniak, CEO of FutureMeds Ltd, United Kingdom (online)
Serhii Mykhailov, Director of Clinical Research in Ukraine, Georgia and the CIS, MSD

Werner Gladdins, Vice President, Program Management / Clinical Development Operations, Immunic Therapeutics, Germany (online)

17.55 – 18.10

The role of a laboratory center accredited according to the requirements of ISO 15189 in conducting clinical research

The role of a laboratory center accredited under the requirements of the ISO 15189 series in conducting clinical research

Anastasia Zhuzhukova,
Anastasia Zhuzhukova, development manager of the CNP «Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of the Cherkasy Regional Council», Cherkasy, Ukraine, clinical research coordinator

Anastasiia Zhuzhukova,
Development Manager at the Municipal Non-Profit Enterprise “Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of the Cherkasy Regional Council,” Cherkasy, Ukraine, clinical research coordinator

18.10– 18.20

DISCUSSION OF THE TOPIC WITH THE AUDIENCE
Forum moderator: Serhii Orlyk,
pharmaceutical market expert

18.20 – 18.30

ADOPTION OF THE RESOLUTION

Oleksandr Hudzenko,
Doctor of Pharmaceutical Sciences, Professor, Honored Worker of Health Care of Ukraine, Head of the Agency for Methodological and Scientific-Practical Work of the State Expert Center of the Ministry of Health of Ukraine, co-chair of the Forum Organizing Committee

18.30

CLOSING OF THE FORUM. BUFFET
Forum Moderator: Serhii Orlyk,
pharmaceutical market expert